-+ 0.00%
-+ 0.00%
-+ 0.00%

Aprogen subsidiary Aprogen Biologics lends KRW 29.1 billion to Ainsfac

PUBT·09/23/2026 07:34:05
Listen to the news
Aprogen subsidiary Aprogen Biologics lends KRW 29.1 billion to Ainsfac
  • Aprogen Biologics set a cash loan of KRW 29.1 billion to Ainsfac, starting Sept. 28, 2026.
  • Loan carries 4.6% interest. Matures Sept. 27, 2027. Amount equals 10.5% of equity.
  • Funds earmarked for strategic cash deployment to improve financial structure.
  • Board decision dated Sept. 23, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aprogen Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260923800573), on September 23, 2026, and is solely responsible for the information contained therein.